Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 9652817, 16 pages
https://doi.org/10.1155/2018/9652817
Review Article

Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer

1Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China
2Nanjing Lishui People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu 211200, China
3The Third People’s Hospital of Sihong County, Suqian, Jiangsu 223911, China

Correspondence should be addressed to Fei Mao; nc.ude.sju@3002iefoam

Received 17 September 2018; Revised 26 November 2018; Accepted 9 December 2018; Published 26 December 2018

Academic Editor: Toshimi Chiba

Copyright © 2018 Jingjing Kang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Desai and N. Desai, “Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis,” World Journal of Gastrointestinal Endoscopy, vol. 6, no. 11, pp. 541–548, 2014. View at Publisher · View at Google Scholar
  2. R. Gao, Z. Gao, L. Huang, and H. Qin, “Gut microbiota and colorectal cancer,” European Journal of Clinical Microbiology & Infectious Diseases Official Publication of the European Society of Clinical Microbiology, vol. 38, 2017. View at Google Scholar
  3. F. De Francesco, M. Romano, L. Zarantonello et al., “The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies,” Cancer Biology & Therapy, vol. 17, no. 9, pp. 889–898, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. Nicholls, “Ulcerative colitis - Surgical indications and treatment,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 4, pp. 25–28, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. D. T. Rubin, A. LoSavio, N. Yadron, D. Huo, and S. B. Hanauer, “Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis,” Clinical Gastroenterology and Hepatology, vol. 4, no. 11, pp. 1346–1350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. B. Hanauer, B. G. Feagan, G. R. Lichtenstein et al., “Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial,” The Lancet, vol. 359, no. 9317, pp. 1541–1549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Dave, K. Mehta, J. Luther, A. Baruah, A. B. Dietz, and W. A. Faubion, “Mesenchymal stem cell therapy for inflammatory bowel disease: A systematic review and meta-analysis,” Inflammatory Bowel Diseases, vol. 21, no. 11, pp. 2696–2707, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Di Franco, M. Todaro, F. Dieli, and G. Stassi, “Colorectal cancer defeating? Challenge accepted!,” Molecular Aspects of Medicine, vol. 39, pp. 61–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Ricart, A. Jauregui-Amezaga, I. Ordás, S. Pinó, A. M. Ramírez, and J. Panés, “Cell therapies for IBD: what works?” Current Drug Targets, vol. 14, no. 12, pp. 1453–1459, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Tang, S. N. Shen, X. Y. Zhao et al., “Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer,” Stem Cell Research & Therapy, vol. 6, 2015. View at Google Scholar
  11. R. Chinnadurai, S. Ng, V. Velu, and J. Galipeau, “Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease,” World Journal of Gastroenterology, vol. 21, no. 16, pp. 4779–4787, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Okamoto and M. Watanabe, “Investigating cell therapy for inflammatory bowel disease,” Expert Opinion on Biological Therapy, vol. 16, no. 8, pp. 1015–1023, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Galipeau, “Mesenchymal Stromal Cells,” in Hematology, chapter 99, pp. 1559–1567, 2018. View at Google Scholar
  14. F. Caprioli, F. Pallone, and G. Monteleone, “Th17 immune response in IBD: A new pathogenic mechanism,” Journal of Crohn's and Colitis, vol. 2, no. 4, pp. 291–295, 2008. View at Google Scholar · View at Scopus
  15. H. S. P. De Souza, C. Fiocchi, and D. Iliopoulos, “The IBD interactome: An integrated view of aetiology, pathogenesis and therapy,” Nature Reviews Gastroenterology & Hepatology, vol. 14, no. 12, pp. 739–749, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Neofytou, T. Deuse, R. E. Beygui, and S. Schrepfer, “Mesenchymal stromal cell therapy: Different sources exhibit different immunobiological properties,” Transplantation, vol. 99, no. 6, pp. 1113–1118, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Sun, G. Z. Gao, R. F. Li et al., “Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice,” American Journal of Translational Research, vol. 7, pp. 891–901, 2015. View at Google Scholar
  18. A. M. Robinson, A. A. Rahman, S. Miller, R. Stavely, S. Sakkal, and K. Nurgali, “The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis,” Stem Cell Research & Therapy, vol. 8, no. 1, 2017. View at Google Scholar · View at Scopus
  19. H. J. Lee, S.-H. Oh, H. W. Jang et al., “Long-term effects of bone marrow-derived mesenchymal stem cells in dextran sulfate sodium-induced murine chronic colitis,” Gut and Liver, vol. 10, no. 3, pp. 412–419, 2016. View at Google Scholar · View at Scopus
  20. R. Ciccocioppo, G. C. Cangemi, P. Kruzliak, and G. R. Corazza, “Cellular therapies: the potential to regenerate and restore tolerance in immune-mediated intestinal diseases,” Stem Cells, vol. 34, no. 6, pp. 1474–1486, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Bassi, L. Pacelli, R. Carusone, J. Zanoncello, and M. Krampera, “Adipose-derived stromal cells (ASCs),” Transfusion and Apheresis Science, vol. 47, no. 2, pp. 193–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Nakao, T. Nakayama, T. Yahata et al., “Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells,” The American Journal of Pathology, vol. 177, no. 2, pp. 547–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, Y. Jin, Y. Lin et al., “Adipose-Derived Mesenchymal Stem Cells Ameliorate Ulcerative Colitis Through MIR-1236 Negatively Regulating the Expression of Retinoid-Related Orphan Receptor Gamma,” DNA and Cell Biology, vol. 34, no. 10, pp. 618–625, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Anderson, L. Souza-Moreira, M. Morell et al., “Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis,” Gut, vol. 62, no. 8, pp. 1131–1141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lopez-Santalla, P. Mancheño-Corvo, A. Escolano et al., “Biodistribution and efficacy of human adipose-derived mesenchymal stem cells following intranodal administration in experimental colitis,” Frontiers in Immunology, vol. 8, 2017. View at Google Scholar · View at Scopus
  26. M. Xie, H. Qin, Q. Luo, X. He, P. Lan, and L. Lian, “Comparison of adipose-derived and bone marrow mesenchymal stromal cells in a murine model of Crohn's disease,” Digestive Diseases & Sciences, vol. 62, pp. 1–9, 2016. View at Google Scholar
  27. R. Stavely, A. M. Robinson, S. Miller, R. Boyd, S. Sakkal, and K. Nurgali, “Human adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis,” Stem Cell Research & Therapy, vol. 6, no. 1, pp. 1–21, 2015. View at Google Scholar · View at Scopus
  28. B. Zhang, X. Wu, X. Zhang et al., “Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway,” Stem Cells Translational Medicine, vol. 4, no. 5, pp. 513–522, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Wang, J. Cai, F. Huang et al., “Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells,” International Journal of Molecular Medicine, vol. 35, no. 2, pp. 367–375, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Cao, H. Qian, W. Xu et al., “Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats,” Biotechnology Letters, vol. 32, no. 5, pp. 725–732, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-S. Kim, T.-H. Shin, B.-C. Lee et al., “Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2,” Gastroenterology, vol. 145, no. 6, pp. 1392.e8–1403.e8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Baksh, R. Yao, and R. S. Tuan, “Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow,” Stem Cells, vol. 25, no. 6, pp. 1384–1392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Mao, Y. Wu, X. Tang et al., “Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice,” BioMed Research International, vol. 2017, Article ID 5356760, 12 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Lv, X. Xu, B. Zhang et al., “Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice,” Journal of Translational Medicine, vol. 12, no. 1, 2014. View at Publisher · View at Google Scholar
  35. A. Zani, M. Cananzi, F. Fascetti-Leon et al., “Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism,” Gut, vol. 63, no. 2, pp. 300–309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Zhang, L. Zheng, H. Shi et al., “Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer,” International Journal of Medical Sciences, vol. 11, no. 9, pp. 870–879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Miyamoto, S. Ohnishi, R. Onishi et al., “Therapeutic effects of human amnion-derived mesenchymal stem cell transplantation and conditioned medium enema in rats with trinitrobenzene sulfonic acid-induced colitis,” American Journal of Translational Research, vol. 9, no. 3, pp. 940–952, 2017. View at Google Scholar · View at Scopus
  38. E. Legaki, M. G. Roubelakis, G. E. Theodoropoulos et al., “Therapeutic potential of secreted molecules derived from human amniotic fluid mesenchymal stem/stroma cells in a mice model of colitis,” Stem Cell Reviews and Reports, vol. 12, no. 5, pp. 604–612, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Xu, C. Chen, K. Akiyama et al., “Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells,” Journal of Dental Research, vol. 92, no. 9, pp. 825–832, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Yu, E. M. Song, K. E. Lee et al., “Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis,” PLoS ONE, vol. 12, no. 8, Article ID e0183141, 2017. View at Publisher · View at Google Scholar
  41. J. M. Lee, J. Jung, H.-J. Lee et al., “Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells,” International Immunopharmacology, vol. 13, no. 2, pp. 219–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. D. G. Phinney, “Functional heterogeneity of mesenchymal stem cells: implications for cell therapy,” Journal of Cellular Biochemistry, vol. 113, no. 9, pp. 2806–2812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Ankrum and J. M. Karp, “Mesenchymal stem cell therapy: two steps forward, one step back,” Trends in Molecular Medicine, vol. 16, no. 5, pp. 203–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. I. J. Fox, G. Q. Daley, S. A. Goldman, J. Huard, T. J. Kamp, and M. Trucco, “Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease,” Science, vol. 345, no. 6199, Article ID 1247391, 2014. View at Publisher · View at Google Scholar
  45. J. Tang, J. Xiong, T. Wu et al., “Aspirin Treatment Improved Mesenchymal Stem Cell Immunomodulatory Properties via the 15d-PGJ2/PPARÎ3/TGF-Î21 Pathway,” Stem Cells & Development, vol. 23, pp. 2093–2103, 2014. View at Google Scholar
  46. A. M. Hoffman and S. W. Dow, “Concise review: stem cell trials using companion animal disease models,” Stem Cells, vol. 34, no. 7, pp. 1709–1729, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Neudecker, M. Haneklaus, O. Jensen et al., “Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome,” The Journal of Experimental Medicine, vol. 214, no. 6, pp. 1737–1752, 2017. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Wu, Y. Liu, Z. Fan et al., “miR-21 modulates the immunoregulatory function of bone marrow mesenchymal stem cells through the PTEN/Akt/TGF-β1 pathway,” Stem Cells, vol. 33, no. 11, pp. 3281–3290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Chen, Y. Song, H. Miao et al., “Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis,” Inflammation Research, vol. 64, no. 9, pp. 671–681, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Liu, D. Zuo, H. Fan et al., “Over-expression of CXCR4 on mesenchymal stem cells protect against experimental colitis via immunomodulatory functions in impaired tissue,” Journal of Molecular Histology, vol. 45, no. 2, pp. 181–193, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Lee, H.-S. Kim, K.-H. Roh et al., “DNA methyltransferase inhibition accelerates the immunomodulation and migration of human mesenchymal stem cells,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Yu, J. Y. Lee, H. Kim et al., “A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging,” PLoS ONE, vol. 9, no. 8, Article ID e102426, 2014. View at Publisher · View at Google Scholar
  53. P. Fuenzalida, M. Kurte, C. Fernández-O'ryan et al., “Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium–induced colitis model,” Cytotherapy, vol. 18, no. 5, pp. 630–641, 2016. View at Publisher · View at Google Scholar
  54. M. R. Irhimeh and J. Cooney, “Management of inflammatory bowel disease using stem cell therapy,” Current Stem Cell Research & Therapy, vol. 11, no. 1, pp. 72–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Shuai, L. Liao, X. Su et al., “Melatonin treatment improves mesenchymal stem cells therapy by preserving stemness during long-term in vitro expansion,” Theranostics, vol. 6, no. 11, pp. 1899–1917, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Jiang, L. Yan, Z. Miao, E. Li, K. H. Wong, and R.-H. Xu, “Spheroidal formation preserves human stem cells for prolonged time under ambient conditions for facile storage and transportation,” Biomaterials, vol. 133, pp. 275–286, 2017. View at Publisher · View at Google Scholar · View at Scopus
  57. I. Molendijk, M. C. Barnhoorn, E. S. M. de Jonge-Muller et al., “Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis,” Journal of Crohn's and Colitis, vol. 10, no. 8, pp. 953–964, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Moll, I. Rasmusson-Duprez, and L. von Bahr, “Are therapeutic human mesenchymal stromal cells compatible with human blood?” Stem Cells, vol. 30, no. 7, pp. 1565–1574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Liu, C. Chen, S. Liu et al., “Acetylsalicylic acid treatment improves differentiation and immunomodulation of SHED,” Journal of Dental Research, vol. 94, no. 1, pp. 209–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Tang, Y. Chen, X. Wang, G. Song, Y. Li, and L. Shi, “Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis,” Digestive Diseases and Sciences, vol. 60, no. 7, pp. 1948–1957, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Forte, M. Ciciarello, M. C. Valerii et al., “Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis,” Stem Cell Research & Therapy, vol. 6, no. 1, article 170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Liao, B. Shi, H. Chang et al., “Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy,” Theranostics, vol. 7, no. 1, pp. 106–116, 2017. View at Publisher · View at Google Scholar · View at Scopus
  63. B. S. Markovic, A. Nikolic, M. Gazdic et al., “Pharmacological inhibition of Gal-3 in mesenchymal stem cells enhances their capacity to promote alternative activation of macrophages in dextran sulphate sodium-induced colitis,” Stem Cells International, vol. 2016, Article ID 2640746, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Robinson, S. Miller, S. Sakkal et al., “Mesenchymal stem cells and conditioned medium avert inflammation-induced enteric neuropathy,” Neurogastroenterology & Motility, vol. 26, p. 17, 2014. View at Google Scholar
  65. Y. Yu, L. Liao, B. Shao et al., “Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy,” Molecular Therapy, vol. 25, no. 2, pp. 480–493, 2017. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Knoop, N. Schwenk, K. Schmohl et al., “Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene,” Journal of Nuclear Medicine, vol. 56, no. 4, pp. 600–606, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Yang, C. H. Zhou, R. Zhu et al., “Microvesicles shuttled mir0b attenuate experimental colitis associated intestinal fibrosis by inhibiting the development of EMT,” Journal of Gastroenterology & Hepatology, 2017. View at Google Scholar
  68. D.-B. Ryu, J.-Y. Lim, S.-E. Lee, G. Park, and C.-K. Min, “Induction of indoleamine 2,3-dioxygenase by pre-treatment with poly(I:C) may enhance the efficacy of MSC treatment in DSS-induced colitis,” Immune Network, vol. 16, no. 6, pp. 358–365, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Qiu, J. Guo, R. Mao et al., “TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway,” Mucosal Immunology, vol. 10, no. 3, pp. 727–742, 2017. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Yu, T. Zhao, and D. Yang, “Cotransfer of regulatory T cells improve the therapeutic effectiveness of mesenchymal stem cells in treating a colitis mouse model,” Journal of Experimental Animal Science, vol. 66, no. 2, pp. 167–176, 2017. View at Publisher · View at Google Scholar · View at Scopus
  71. D. I. Cho, R. K. Mi, H. Jeong et al., “Mesenchymal stem cells reciprocally regulate the M1|[sol]|M2 balance in mouse bone marrow-derived macrophages,” Experimental Molecular Medicine, vol. 46, 2014. View at Google Scholar
  72. V. Holan, B. Hermankova, P. Bohacova et al., “Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment,” Stem Cell Reviews and Reports, vol. 12, no. 6, pp. 654–663, 2016. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Wang, C. Liang, H. Hu et al., “Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis,” Scientific Reports, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  74. M. A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado, “Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses,” Gastroenterology, vol. 136, no. 3, pp. 978–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. I. K. Ko, B.-G. Kim, A. Awadallah et al., “Targeting improves MSC treatment of inflammatory bowel disease,” Molecular Therapy, vol. 18, no. 7, pp. 1365–1372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Zheng, W. Wu, S. Yang et al., “Treatment of radiation-induced acute intestinal injury with bone marrow-derived mesenchymal stem cells,” Experimental and Therapeutic Medicine, vol. 11, no. 6, pp. 2425–2431, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Yemm, D. Adams, and N. Kalia, “Targeting the delivery of systemically administered haematopoietic stem/progenitor cells to the inflamed colon using hydrogen peroxide and platelet microparticle pre-treatment strategies,” Stem Cell Research, vol. 15, no. 3, pp. 569–580, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. G. Ren, L. Zhang, X. Zhao et al., “Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide,” Cell Stem Cell, vol. 2, no. 2, pp. 141–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. Q.-Q. Chen, L. Yan, C.-Z. Wang et al., “Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses,” World Journal of Gastroenterology, vol. 19, no. 29, pp. 4702–4717, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. M. P. de Miguel, S. Fuentes-Julián, A. Blázquez-Martínez et al., “Immunosuppressive properties of mesenchymal stem cells: advances and applications,” Current Molecular Medicine, vol. 12, no. 5, pp. 574–591, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Chao, S. Zhang, Y. Qiu et al., “Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells,” Stem Cell Research & Therapy, vol. 7, no. 1, pp. 1–12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  82. E. Sala, M. Genua, L. Petti et al., “Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine,” Gastroenterology, vol. 149, no. 1, Article ID 59674, pp. 163–176, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. L.-T. Wang, C.-H. Ting, M.-L. Yen et al., “Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials,” Journal of Biomedical Science, vol. 23, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Wang, X. Chen, W. Cao, and Y. Shi, “Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications,” Nature Immunology, vol. 15, no. 11, pp. 1009–1016, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Zuo, Q. Tang, H. Fan et al., “Modulation of nuclear factor-κB-mediated pro-inflammatory response is associated with exogenous administration of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis,” Molecular Medicine Reports, vol. 11, no. 4, pp. 2741–2748, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Fan, G. Zhao, L. Liu et al., “Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis,” Cellular & Molecular Immunology, vol. 9, no. 6, pp. 473–481, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Yu, B. Shao, Y. Shuai et al., “Role of bone marrow-derived mesenchymal stem cells in treating colitis through Fas/FasL-mediated immune regulation,” Chinese Journal of Cellular and Molecular Immunology, vol. 29, no. 10, pp. 1028–1031, 2013. View at Google Scholar · View at Scopus
  88. T.-H. Tran, G. Mattheolabakis, H. Aldawsari, and M. Amiji, “Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases,” Clinical Immunology, vol. 160, no. 1, pp. 46–58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. D. W. Greening, S. K. Gopal, R. Xu, R. J. Simpson, and W. Chen, “Exosomes and their roles in immune regulation and cancer,” Seminars in Cell & Developmental Biology, vol. 40, pp. 72–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. R. C. Lai, R. W. Y. Yeo, and S. K. Lim, “Mesenchymal stem cell exosomes,” Seminars in Cell & Developmental Biology, vol. 40, pp. 82–88, 2015. View at Publisher · View at Google Scholar
  91. J. Burrello, S. Monticone, C. Gai, Y. Gomez, S. Kholia, and G. Camussi, “Stem cell-derived extracellular vesicles and immune-modulation,” Frontiers in Cell Developmental Biology, vol. 4, 2016. View at Google Scholar
  92. K.-C. Lin, H.-K. Yip, P.-L. Shao et al., “Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury,” International Journal of Cardiology, vol. 216, pp. 173–185, 2016. View at Publisher · View at Google Scholar · View at Scopus
  93. F. Arslan, R. C. Lai, M. B. Smeets et al., “Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury,” Stem Cell Research, vol. 10, no. 3, pp. 301–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Mao, Y. Wu, X. Tang et al., “Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages,” Biotechnology Letters, vol. 39, no. 6, pp. 929–938, 2017. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Yang, X.-X. Liu, H. Fan et al., “Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis,” PLoS ONE, vol. 10, Article ID e0140551, 2015. View at Google Scholar · View at Scopus
  96. T. M. Rager, J. K. Olson, Y. Zhou, Y. Wang, and G. E. Besner, “Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis,” Journal of Pediatric Surgery, vol. 51, no. 6, pp. 942–947, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Record, K. Carayon, M. Poirot, and S. Silvente-Poirot, “Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1841, no. 1, pp. 108–120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. F. Collino, M. C. Deregibus, S. Bruno et al., “Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs,” PLoS ONE, vol. 5, no. 7, Article ID e11803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Ti, H. Hao, X. Fu, and W. Han, “Mesenchymal stem cells-derived exosomal microRNAs contribute to wound inflammation,” Science China Life Sciences, vol. 59, no. 12, pp. 1305–1312, 2016. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Yanez-Mo, P. R. Siljander, and Z. Andreu, “Biological properties of extracellular vesicles and their physiological functions,” Journal of Extracellular Vesicles, vol. 4, Article ID 27066, 2015. View at Publisher · View at Google Scholar
  101. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” Ca A Cancer Journal for Clinicians, vol. 65, pp. 87–108, 2015. View at Google Scholar
  102. V. Koliaraki, C. K. Pallangyo, F. R. Greten, and G. Kollias, “Mesenchymal Cells in Colon Cancer,” Gastroenterology, vol. 152, no. 5, pp. 964–979, 2017. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Bajetto, A. Pattarozzi, A. Corsaro et al., “Different effects of human umbilical cord mesenchymal stem cells on glioblastoma stem cells by direct cell interaction or via released soluble factors,” Frontiers in Cellular Neuroscience, vol. 11, 2017. View at Google Scholar · View at Scopus
  104. L. Yang, Y. Zhang, L. Cheng et al., “Mesenchymal stem cells engineered to secrete pigment epithelium-derived factor inhibit tumor metastasis and the formation of malignant ascites in a murine colorectal peritoneal carcinomatosis model,” Human Gene Therapy, vol. 27, no. 3, pp. 267–277, 2016. View at Publisher · View at Google Scholar · View at Scopus
  105. E. Z. Keung, P. J. Nelson, and C. Conrad, “Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy,” Stem Cells, vol. 31, no. 2, pp. 227–235, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Gwendal and L. Paula Y, “Recent discoveries concerning the tumor - mesenchymal stem cell interactions,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1866, no. 2, pp. 290–299, 2016. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Nasuno, Y. Arimura, K. Nagaishi et al., “Mesenchymal stem cells cancel azoxymethane-induced tumor initiation,” Stem Cells, vol. 32, no. 4, pp. 913–925, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. Z. Chen, X. He, X. He et al., “Bone marrow mesenchymal stem cells ameliorate colitis-Associated tumorigenesis in mice,” Biochemical and Biophysical Research Communications, vol. 450, no. 4, pp. 1402–1408, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. H. Feng, J.-K. Zhao, T. S. Schiergens et al., “Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation,” British Journal of Cancer, vol. 118, no. 3, pp. 353–365, 2018. View at Publisher · View at Google Scholar · View at Scopus
  110. F. Hendijani and S. H. Javanmard, “Dual protective and cytotoxic benefits of mesenchymal stem cell therapy in combination with chemotherapy/radiotherapy for cancer patients,” Critical Reviews in Eukaryotic Gene Expression, vol. 25, no. 3, pp. 203–208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. P. E. Drakos, A. Nagler, and R. Or, “Case of Crohn's disease in bone marrow transplantation,” American Journal of Hematology, vol. 43, no. 2, pp. 157-158, 1993. View at Publisher · View at Google Scholar · View at Scopus
  112. O. V. Kniazev, A. I. Parfenov, I. N. Ruchkina, L. B. Lazebnik, and V. É. Sagynbaeva, “Immune response to biological therapy of inflammatory bowel diseases,” Terapevticheskii Arkhiv, vol. 85, pp. 55–59, 2013. View at Google Scholar
  113. J. Panés, D. Garcia-Olmo, and G. Van Assche, “Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial,” The Lancet, vol. 388, no. 10051, pp. 1281–1290, 2016. View at Publisher · View at Google Scholar
  114. F. De La Portilla, F. Alba, D. García-Olmo, J. M. Herrerías, F. X. González, and A. Galindo, “Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial,” International Journal of Colorectal Disease, vol. 28, no. 3, pp. 313–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. I. Molendijk, B. A. Bonsing, H. Roelofs et al., “Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease,” Gastroenterology, vol. 149, no. 4, pp. 918–927, 2015. View at Publisher · View at Google Scholar · View at Scopus
  116. G. M. Forbes, M. J. Sturm, R. W. Leong et al., “A phase 2 study of allogeneic mesenchymal stromal cells for luminal crohn's disease refractory to biologic therapy,” Clinical Gastroenterology and Hepatology, vol. 12, no. 1, pp. 64–71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. M. Duijvestein, A. C. W. Vos, H. Roelofs et al., “Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study,” Gut, vol. 59, no. 12, pp. 1662–1669, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. A. B. Dietz, E. J. Dozois, J. G. Fletcher et al., “Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with crohn's disease,” Gastroenterology, vol. 153, no. 1, pp. 59–62, 2017. View at Publisher · View at Google Scholar · View at Scopus
  119. Y. B. Cho, W. Y. Lee, K. J. Park, M. Kim, H.-W. Yoo, and C. S. Yu, “Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula. A phase I clinical study,” Cell Transplantation, vol. 22, no. 2, pp. 279–285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. T. Dhere, I. Copland, M. Garcia et al., “The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses,” Alimentary Pharmacology & Therapeutics, vol. 44, no. 5, pp. 471–481, 2016. View at Publisher · View at Google Scholar · View at Scopus
  121. W. Y. Lee, K. J. Park, Y. B. Cho et al., “Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for crohn's fistula,” Stem Cells, vol. 31, no. 11, pp. 2575–2581, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. R. Ciccocioppo, M. E. Bernardo, A. Sgarella et al., “Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease,” Gut, vol. 60, no. 6, pp. 788–798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Liang, H. Zhang, D. Wang et al., “Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease,” Gut, vol. 61, no. 3, pp. 468-469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. M. E. Bernardo and W. E. Fibbe, “Mesenchymal stromal cells and hematopoietic stem cell transplantation,” Immunology Letters, vol. 168, no. 2, pp. 215–221, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Scharl, “Treatment of chronic inflammatory bowel diseases: What is next?” Praxis, vol. 103, no. 4, pp. 185-186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. M. J. Hoogduijn, M. Roemeling-Van Rhijn, S. S. Korevaar, A. U. Engela, W. Weimar, and C. C. Baan, “Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies,” Human Gene Therapy, vol. 22, no. 12, pp. 1587–1591, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. V. Purpura, E. Bondioli, D. Melandri, P. C. Parodi, L. Valenti, and M. Riccio, “The collection of adipose derived stem cells using waterjet assisted lipoplasty for their use in plastic and reconstructive surgery: a preliminary study,” Frontiers in Cell Developmental Biology, vol. 4, 2016. View at Google Scholar
  128. D. Oehme, P. Ghosh, T. Goldschlager et al., “Reconstitution of degenerated ovine lumbar discs by STRO-3–positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate,” Journal of Neurosurgery: Spine, vol. 24, no. 5, pp. 715–726, 2016. View at Publisher · View at Google Scholar
  129. Y. Wang, A. Shimmin, P. Ghosh et al., “Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: A controlled double-blind randomised trial,” Arthritis Research & Therapy, vol. 19, no. 1, 2017. View at Google Scholar · View at Scopus
  130. S. G. Royce, S. Rele, B. R. S. Broughton, K. Kelly, and C. S. Samuel, “Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease,” The FASEB Journal, vol. 31, no. 9, pp. 4168–4178, 2017. View at Publisher · View at Google Scholar · View at Scopus
  131. B. Wagner and R. Henschler, “Fate of Intravenously Injected Mesenchymal Stem Cells and Significance for Clinical Application,” Advances in Biochemical Engineering-Biotechnology, vol. 130, pp. 19–37, 2013. View at Google Scholar
  132. D. García-Olmo, D. Herreros, P. De-La-Quintana et al., “Adipose-derived stem cells in Crohn's rectovaginal fistula,” Case Reports in Medicine, vol. 2010, Article ID 961758, 3 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Ahrendt, S. I. Hammerschmidt, O. Pabst, R. Pabst, and U. Bode, “Stromal cells confer lymph node-specific properties by shaping a unique microenvironment influencing local immune responses,” The Journal of Immunology, vol. 181, no. 3, pp. 1898–1907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. M. D. P. Martínez-Montiel, G. J. Gómez-Gómez, and A. I. Flores, “Therapy with stem cells in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 20, no. 5, pp. 1211–1227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  135. A. S. Bhatt, S. Freeman, A. Herrera et al., “Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome,” Biology of Blood & Marrow Transplantation, vol. 19, pp. S281–S282, 2013. View at Google Scholar
  136. L. de Girolamo, E. Lucarelli, G. Alessandri et al., “Mesenchymal stem/stromal cells: a new ‘cells as drugs’ paradigm. Efficacy and critical aspects in cell therapy,” Current Pharmaceutical Design, vol. 19, no. 13, pp. 2459–2473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. S. Gatti, S. Bruno, M. C. Deregibus et al., “Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury,” Nephrology Dialysis Transplantation , vol. 26, no. 5, pp. 1474–1483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. B. Zhang, M. Wang, A. Gong et al., “HucMSc-exosome mediated-Wnt4 signaling is required for cutaneous wound healing,” Stem Cells, vol. 33, no. 7, pp. 2158–2168, 2015. View at Publisher · View at Google Scholar · View at Scopus
  139. H. Shi, X. Xu, B. Zhang et al., “3,3-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing,” Theranostics, vol. 7, no. 6, pp. 1674–1688, 2017. View at Publisher · View at Google Scholar · View at Scopus